Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sameer Jauhar

Showing results (61-70 of 138) with videos related to

Pageof 14
Sort By:
BMC Psychology|July 19, 2018
Cognitive Behavioural Therapy for schizophrenia - outcomes for functioning, distress and quality of life: a meta-analysisKeith R Laws, Nicole Darlington, Tejinder K Kondel, et al.
Schizophrenia Research|March 19, 2013
Has the prevalence, clinical presentation and social functioning of schizophrenia changed over the last 25 years? Nithsdale schizophrenia survey revisitedSomashekara Shivashankar, Susan Telfer, Jeyarani Arunagiriraj, et al.
Journal of Psychiatric Research|December 16, 2014
Commentary on a study of the prevalence of mental disorders by Breslau et alMichael A P Bloomfield, Sameer Jauhar, Sean Froudist-Walsh, et al.
JAMA Psychiatry|January 19, 2017
Impaired Glucose Homeostasis in First-Episode Schizophrenia: A Systematic Review and Meta-analysisToby Pillinger, Katherine Beck, Cristian Gobjila, et al.
Frontiers in Psychiatry|August 28, 2020
Methodological Biases in CBT Trial-Commentary: Modular Cognitive-Behavioral Therapy for Affective Symptoms in Young Individuals at Ultra-High Risk of First Episode of Psychosis: Randomized Controlled TrialPaolo Fusar-Poli, Joaquim Radua, Peter J McKenna, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 26, 2019
Glutamatergic function in a genetic high-risk group for psychosis: A proton magnetic resonance spectroscopy study in individuals with 22q11.2 deletionMaria Rogdaki, Pamela Hathway, Maria Gudbrandsen, et al.
Schizophrenia Bulletin|October 5, 2023
Does Slow and Steady Win the Race? Rates of Antipsychotic Discontinuation, Antipsychotic Dose, and Risk of Psychotic RelapseRobert A McCutcheon, David Taylor, Jose Rubio, et al.
Journal of Psychopharmacology (Oxford, England)|May 22, 2019
Antidepressants, withdrawal, and addiction; where are we now?Sameer Jauhar, Joseph Hayes, Guy M Goodwin, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 9, 2004
Analysis of factors that predict alcohol relapse following liver transplantationSameer Jauhar, Jayant A Talwalkar, Terry Schneekloth, et al.
Frontiers in Psychiatry|December 17, 2020
Early Intervention Services for First Episode of Psychosis in South London and the Maudsley (SLaM): 20 Years of Care and Research for Young PeoplePaolo Fusar-Poli, Serena Lai, Marta Di Forti, et al.
Pageof 14

Showing results (61-70 of 138) with videos related to

Sort By:
Pageof 14
BMC Psychology|July 19, 2018
Cognitive Behavioural Therapy for schizophrenia - outcomes for functioning, distress and quality of life: a meta-analysisKeith R Laws, Nicole Darlington, Tejinder K Kondel, et al.
Schizophrenia Research|March 19, 2013
Has the prevalence, clinical presentation and social functioning of schizophrenia changed over the last 25 years? Nithsdale schizophrenia survey revisitedSomashekara Shivashankar, Susan Telfer, Jeyarani Arunagiriraj, et al.
Journal of Psychiatric Research|December 16, 2014
Commentary on a study of the prevalence of mental disorders by Breslau et alMichael A P Bloomfield, Sameer Jauhar, Sean Froudist-Walsh, et al.
JAMA Psychiatry|January 19, 2017
Impaired Glucose Homeostasis in First-Episode Schizophrenia: A Systematic Review and Meta-analysisToby Pillinger, Katherine Beck, Cristian Gobjila, et al.
Frontiers in Psychiatry|August 28, 2020
Methodological Biases in CBT Trial-Commentary: Modular Cognitive-Behavioral Therapy for Affective Symptoms in Young Individuals at Ultra-High Risk of First Episode of Psychosis: Randomized Controlled TrialPaolo Fusar-Poli, Joaquim Radua, Peter J McKenna, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 26, 2019
Glutamatergic function in a genetic high-risk group for psychosis: A proton magnetic resonance spectroscopy study in individuals with 22q11.2 deletionMaria Rogdaki, Pamela Hathway, Maria Gudbrandsen, et al.
Schizophrenia Bulletin|October 5, 2023
Does Slow and Steady Win the Race? Rates of Antipsychotic Discontinuation, Antipsychotic Dose, and Risk of Psychotic RelapseRobert A McCutcheon, David Taylor, Jose Rubio, et al.
Journal of Psychopharmacology (Oxford, England)|May 22, 2019
Antidepressants, withdrawal, and addiction; where are we now?Sameer Jauhar, Joseph Hayes, Guy M Goodwin, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 9, 2004
Analysis of factors that predict alcohol relapse following liver transplantationSameer Jauhar, Jayant A Talwalkar, Terry Schneekloth, et al.
Frontiers in Psychiatry|December 17, 2020
Early Intervention Services for First Episode of Psychosis in South London and the Maudsley (SLaM): 20 Years of Care and Research for Young PeoplePaolo Fusar-Poli, Serena Lai, Marta Di Forti, et al.
Pageof 14